[go: up one dir, main page]

NO20022990L - Fremgangsmåte og sammensetning for behandling av smerte - Google Patents

Fremgangsmåte og sammensetning for behandling av smerte

Info

Publication number
NO20022990L
NO20022990L NO20022990A NO20022990A NO20022990L NO 20022990 L NO20022990 L NO 20022990L NO 20022990 A NO20022990 A NO 20022990A NO 20022990 A NO20022990 A NO 20022990A NO 20022990 L NO20022990 L NO 20022990L
Authority
NO
Norway
Prior art keywords
pain
treatment
composition
Prior art date
Application number
NO20022990A
Other languages
English (en)
Other versions
NO20022990D0 (no
Inventor
Vernon Alford
Thomas Michael Bare
Dean Gordon Brown
Frances Marie Mclaren
Megan Murphy
Rebecca Ann Urbanek
Wenhua Xiao
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20022990D0 publication Critical patent/NO20022990D0/no
Publication of NO20022990L publication Critical patent/NO20022990L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022990A 1999-12-23 2002-06-20 Fremgangsmåte og sammensetning for behandling av smerte NO20022990L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17190699P 1999-12-23 1999-12-23
US23683500P 2000-09-29 2000-09-29
PCT/SE2000/002605 WO2001047523A1 (en) 1999-12-23 2000-12-19 Method and composition for the treatment of pain

Publications (2)

Publication Number Publication Date
NO20022990D0 NO20022990D0 (no) 2002-06-20
NO20022990L true NO20022990L (no) 2002-08-20

Family

ID=26867559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022990A NO20022990L (no) 1999-12-23 2002-06-20 Fremgangsmåte og sammensetning for behandling av smerte

Country Status (23)

Country Link
US (1) US20030162783A1 (no)
EP (1) EP1248621A1 (no)
JP (1) JP2003518499A (no)
KR (1) KR20020062983A (no)
CN (1) CN1434714A (no)
AR (1) AR027038A1 (no)
AU (1) AU783499B2 (no)
BG (1) BG106832A (no)
BR (1) BR0016646A (no)
CA (1) CA2394561A1 (no)
CO (1) CO5271687A1 (no)
EE (1) EE200200348A (no)
HK (1) HK1048767A1 (no)
HU (1) HUP0300043A3 (no)
IL (1) IL150202A0 (no)
IS (1) IS6428A (no)
MX (1) MXPA02006154A (no)
NO (1) NO20022990L (no)
NZ (1) NZ519389A (no)
PL (1) PL355850A1 (no)
RU (1) RU2238094C2 (no)
SK (1) SK8802002A3 (no)
WO (1) WO2001047523A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1325004A1 (en) * 2000-09-29 2003-07-09 AstraZeneca AB 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain
DE60119949T2 (de) * 2000-09-29 2007-04-26 Astrazeneca Ab 1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE ANWENDUNG IN DER BEHANDLUNG VON SCHMERZEN
AU2002214441A1 (en) * 2000-09-29 2002-04-08 Astrazeneca Ab 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
SE0403172D0 (sv) * 2004-12-23 2004-12-23 Astrazeneca Ab Manufacturing process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420590D0 (en) * 1993-10-22 1994-11-30 Zeneca Ltd Pyridazino quinoline compounds
US6730675B2 (en) * 1999-12-23 2004-05-04 Astrazeneca Ab Compounds and methods for the treatment of pain
JP2003519148A (ja) * 1999-12-23 2003-06-17 アストラゼネカ・アクチエボラーグ 痛みの処置のための化合物および方法
EP1244664A1 (en) * 1999-12-23 2002-10-02 AstraZeneca AB Compounds and methods for the treatment of pain

Also Published As

Publication number Publication date
EP1248621A1 (en) 2002-10-16
US20030162783A1 (en) 2003-08-28
AR027038A1 (es) 2003-03-12
BG106832A (bg) 2003-03-31
HUP0300043A2 (en) 2003-05-28
RU2238094C2 (ru) 2004-10-20
PL355850A1 (en) 2004-05-31
NO20022990D0 (no) 2002-06-20
KR20020062983A (ko) 2002-07-31
AU2566001A (en) 2001-07-09
HK1048767A1 (zh) 2003-04-17
NZ519389A (en) 2004-05-28
CA2394561A1 (en) 2001-07-05
JP2003518499A (ja) 2003-06-10
IL150202A0 (en) 2002-12-01
SK8802002A3 (en) 2003-06-03
CN1434714A (zh) 2003-08-06
HUP0300043A3 (en) 2007-05-02
EE200200348A (et) 2003-08-15
IS6428A (is) 2002-06-19
CO5271687A1 (es) 2003-04-30
MXPA02006154A (es) 2002-12-05
BR0016646A (pt) 2002-10-08
AU783499B2 (en) 2005-11-03
WO2001047523A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
PT1231887E (pt) Método e composição para o tratamento de cicatrizes
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO20006604D0 (no) Fremgangsmåter og transdermale sammensetninger for lindring av smerte
NO985484L (no) FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi
NO20005017L (no) Metoder og viskøse sammensetninger for behandling av brønner
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
IS4805A (is) Aðferð til meðhöndlunar og lyfjasamsetning
NO20015772L (no) Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte
AU2420101A (en) Method and composition for the treatment of pain
AU2566201A (en) Compounds and methods for the treatment of pain
NO20022984D0 (no) Forbindelse og fremgangsmåte for behandling av smerte
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
GB9904252D0 (en) Composition for the treatment of pain
AU2420201A (en) Compounds and methods for the treatment of pain
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
NO20014476D0 (no) Behandling av hiatial hernia
GB9903950D0 (en) Method of treatment
TJ99000556A (en) Method of treatment of nevrodermite

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application